Drug Profile
Levonorgestrel implant
Alternative Names: Jadelle; Norplant-2Latest Information Update: 28 Oct 2021
Price :
$50
*
At a glance
- Originator Population Council (USA)
- Developer Bayer; Pfizer; Population Council (USA)
- Class Hormonal contraceptives; Hormonal replacements; Norpregnanes; Progesterone congeners; Small molecules
- Mechanism of Action Progesterone receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Pregnancy
Most Recent Events
- 31 Mar 2015 The product is approved for Contraception in USA, France, Iceland and Luxembourg
- 16 Dec 2011 Launched for Pregnancy (Prevention) in New Zealand (Subcutaneous)
- 27 Oct 2010 Registered for Pregnancy (Prevention) in New Zealand (Subcutaneous)